Overview Financials News + Filings IR Vault Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Employment agrmnt
Director departure
Inv. presentation
Quarterly results
Appointed director
CC transcript
|
|
OSI PHARMACEUTICALS INC (OSIP)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 06/19/2007 |
8-K
| Appointed a new director |
| 04/22/2005 |
8-K
| Appointed a new director|
Docs:
|
"Employment Separation Agreement and Release of Legal Rights, by and between OSI Pharmaceuticals, Inc. and Nicole Onetto, M.D",
"Employment Agreement, by and between OSI Pharmaceuticals, Inc. and Michael G. Atieh",
"OSI PHARMACEUTICALS ANNOUNCES ACQUISITION OF ALL MINORITY INTEREST SHARES OF PROSIDION LIMITED, UK-BASED DIABETES AND OBESITY SUBSIDIARY",
"OSI PHARMACEUTICALS SUMMARIZES PRE-CLINICAL DATA FROM ITS RESEARCH & DEVELOPMENT PROGRAM PRESENTED AT THE 96TH ANNUAL MEETING OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH",
"OSI PHARMACEUTICALS PRESENTS DATA ON THE IMPACT OF SMOKING ON THE BLOOD LEVELS OF TARCEVA AT THE 96TH ANNUAL MEETING OF THE AACR",
"OSI PHARMACEUTICALS ANNOUNCES REALIGNMENT AND STRENGTHENING OF THE COMPANY'S EXECUTIVE MANAGEMENT TEAM AND BOARD OF DIRECTORS - MICHAEL G. ATIEH APPOINTED EXECUTIVE VICE PRESIDENT AND CHIEF FINANCIAL OFFICER - - KATHARINE B. STEVENSON, APPOINTED TO THE BOARD OF DIRECTORS, WILL ASSUME CHAIRMANSHIP OF THE COMPANY'S AUDIT COMMITTEE -" |
|
|
|